AN2 Therapeutics, Inc. Financial Overview
AN2 Therapeutics, Inc.'s market cap is currently $30.69M. The company's EPS TTM is $-0.31; its P/E ratio is -0.99; AN2 Therapeutics, Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
